Jan 17, 2023 08:40AM
Jan 17, 2023 08:00AM
Nov 14, 2022 04:05PM
Sep 28, 2022 04:09PM
Sep 28, 2022 04:09PM
Aug 9, 2022 04:15PM
May 17, 2022 08:08AM Idera Pharma (IDRA) Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC, Enrollment Stopped Early for Efficacy
May 17, 2022 08:04AM
May 5, 2022 04:15PM
Mar 31, 2022 04:15PM
Dec 14, 2021 04:32PM
Dec 14, 2021 04:32PM
Nov 8, 2021 04:14PM
Aug 9, 2021 04:15PM Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Apr 29, 2021 04:10PM
Mar 19, 2021 09:29AM
Mar 18, 2021 04:16PM
Mar 18, 2021 04:15PM
Mar 1, 2021 04:35PM
Jan 11, 2021 06:02AM
Dec 15, 2020 08:13AM Idera Pharma (IDRA) Announces $5 Million in Further Proceeds from Private Placement of up to $20.7 Million
Dec 15, 2020 08:05AM
Nov 17, 2020 04:27PM
Nov 17, 2020 04:27PM
Oct 29, 2020 04:36PM
Sep 28, 2020 08:45AM
Sep 28, 2020 08:45AM
Sep 15, 2020 07:18AM Idera Pharmaceuticals to Present Tilsotolimod Data at ESMO Virtual Congress 2020
Aug 4, 2020 04:10PM
Jul 15, 2020 08:05AM
Jul 15, 2020 08:05AM
Jun 2, 2020 08:16AM
Jun 2, 2020 08:15AM
Apr 30, 2020 04:35PM
Apr 23, 2020 07:30AM Idera Pharmaceuticals Announces Tilsotolimod Program Updates to be Presented at AACR Virtual Annual Meeting 2020
Apr 21, 2020 07:34AM
Apr 21, 2020 07:30AM
Apr 7, 2020 04:11PM
Apr 7, 2020 04:05PM
Mar 12, 2020 07:30AM
Mar 5, 2020 07:00AM
Jan 14, 2020 07:01AM Idera Pharma (IDRA) Announces Update and Corporate Outlook for 2020
Jan 14, 2020 07:00AM
Dec 23, 2019 09:22AM
Dec 23, 2019 09:15AM
Nov 6, 2019 04:01PM
Oct 21, 2019 07:04AM
Oct 21, 2019 07:00AM
Sep 30, 2019 07:30AM Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab and Ipilimumab for the Treatment of Solid Tumors
Sep 4, 2019 07:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All